Figure 3—figure supplement 2. | Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Open accessCopyright infoDownload PDFDownload figures

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Figure 3—figure supplement 2.

Affiliation details

University of Washington, United States; Fred Hutchinson Cancer Research Center, United States; University of Missouri, United States
Figure 3—figure supplement 2.
Download figureOpen in new tabFigure 3—figure supplement 2. Cancer incidence of male mice with rapamycin injection at 8 mg/kg/day for 3 months.

(A) Hematopoietic cancer incidence of rapamycin-treated (15 male) and vehicle-treated (14 male) mice. (B) Incidence of multiple organ invasion of hematopoietic tumors in rapamycin-treated (9 male) and vehicle-treated (14 male) hematopoietic tumor-bearing mice. (C) Non-systemic hematopoietic cancer incidence of rapamycin-treated (15 male) and vehicle-treated (14 male) mice. **p<0.01.

DOI: http://dx.doi.org/10.7554/eLife.16351.015